Matteo Levisetti

2.6k total citations
32 papers, 2.1k citations indexed

About

Matteo Levisetti is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Matteo Levisetti has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 16 papers in Surgery and 10 papers in Immunology. Recurrent topics in Matteo Levisetti's work include Diabetes and associated disorders (17 papers), Pancreatic function and diabetes (14 papers) and Diabetes Management and Research (7 papers). Matteo Levisetti is often cited by papers focused on Diabetes and associated disorders (17 papers), Pancreatic function and diabetes (14 papers) and Diabetes Management and Research (7 papers). Matteo Levisetti collaborates with scholars based in United States, France and Poland. Matteo Levisetti's co-authors include William Pugh, K. S. Polonsky, Emil R. Unanue, Susan Bonner‐Weir, J. B. Clark, Alfred Pick, Anish Suri, Séamus Sreenan, Aaron C. Baldwin and Shirley J. Petzold and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Matteo Levisetti

30 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matteo Levisetti United States	18	1.3k	1.1k	667	622	491	32	2.1k
Chengyang Liu United States	27	1.8k 1.4×	1.0k 1.0×	862 1.3×	1.2k 2.0×	207 0.4×	51	2.8k
Fabrice Moore Belgium	19	1.1k 0.9×	871 0.8×	377 0.6×	667 1.1×	535 1.1×	25	2.1k
Yves Heremans Belgium	26	1.7k 1.3×	920 0.9×	599 0.9×	937 1.5×	220 0.4×	54	2.3k
Michael C. Lawrence United States	22	816 0.6×	355 0.3×	269 0.4×	702 1.1×	132 0.3×	60	1.5k
Angela Koh Canada	10	562 0.4×	349 0.3×	290 0.4×	545 0.9×	96 0.2×	20	1.3k
Tilo Moede Sweden	20	1.2k 0.9×	610 0.6×	585 0.9×	990 1.6×	103 0.2×	33	2.0k
Runpei Wu United States	24	627 0.5×	338 0.3×	290 0.4×	743 1.2×	1.3k 2.7×	36	2.5k
Judith Magenheim Israel	15	544 0.4×	302 0.3×	182 0.3×	704 1.1×	102 0.2×	24	1.3k
Pascale Ribaux Switzerland	18	626 0.5×	573 0.5×	265 0.4×	682 1.1×	300 0.6×	34	1.6k
Nihan Kavaslar Canada	9	405 0.3×	967 0.9×	193 0.3×	896 1.4×	252 0.5×	10	1.9k

Countries citing papers authored by Matteo Levisetti

Since Specialization

Citations

This map shows the geographic impact of Matteo Levisetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Levisetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Levisetti more than expected).

Fields of papers citing papers by Matteo Levisetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Levisetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Levisetti. The network helps show where Matteo Levisetti may publish in the future.

Co-authorship network of co-authors of Matteo Levisetti

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Levisetti. A scholar is included among the top collaborators of Matteo Levisetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Levisetti. Matteo Levisetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colevas, A. Dimitrios, Christine H. Chung, Douglas R. Adkins, et al.. (2024). A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC).. Journal of Clinical Oncology. 42(16_suppl). 6004–6004. 8 indexed citations

Zaretsky, Jesse M., Jessica Ley, Peter Oppelt, et al.. (2023). Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.. Journal of Clinical Oncology. 41(16_suppl). TPS6109–TPS6109. 1 indexed citations

Chung, Christine H., A. Dimitrios Colevas, Douglas R. Adkins, et al.. (2022). A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer.. Journal of Clinical Oncology. 40(16_suppl). 6045–6045. 9 indexed citations

Girgis, Natasha, Steven Hatfield, Fan Zhao, et al.. (2021). 720 CUE-102 selectively activates and expands WT1-specific T cells for the treatment of patients with WT1+ malignancies. SHILAP Revista de lepidopterología. A749–A749. 1 indexed citations

Williams, Jason H., Chandrasekhar Udata, Bishu Ganguly, et al.. (2020). Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes. The AAPS Journal. 22(2). 23–23. 10 indexed citations

Herold, Kevan C., Samantha Bucktrout, Bruce W. Bode, et al.. (2019). Immunomodulatory activity of humanized anti–IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes. JCI Insight. 4(24). 27 indexed citations

Gumbiner, Barry, Tenshang Joh, Liang Hong, et al.. (2017). The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies. Cardiovascular Therapeutics. 36(1). 14 indexed citations

Nemunaitis, John, Hossein Borghaei, Wallace Akerley, et al.. (2017). P2.06-014 Phase 2 Study of Glesatinib or Sitravatinib with Nivolumab in Non-Small Cell Lung Cancer (NSCLC) after Checkpoint Inhibitor Therapy. Journal of Thoracic Oncology. 12(1). S1078–S1078. 3 indexed citations

Mohan, James F., Matteo Levisetti, Boris Calderón, et al.. (2010). Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nature Immunology. 11(4). 350–354. 147 indexed citations

10.

Suri, Anish, Matteo Levisetti, & Emil R. Unanue. (2007). Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?. Current Opinion in Immunology. 20(1). 105–110. 37 indexed citations

11.

Suri, Anish, James J. Walters, Matteo Levisetti, Michael L. Gross, & Emil R. Unanue. (2006). Identification of naturally processed peptides bound to the class I MHC molecule H‐2K^d of normal and TAP‐deficient cells. European Journal of Immunology. 36(3). 544–557. 21 indexed citations

12.

Levisetti, Matteo & Kenneth S. Polonsky. (2005). Diabetic pancreatic β cells ARNT all they should be. Cell Metabolism. 2(2). 78–80. 10 indexed citations

13.

Unanue, Emil R., Craig A. Byersdorfer, Javier A. Carrero, et al.. (2005). Antigen Presentation: Lysoyme, Autoimmune Diabetes, and Listeria What Do They Have in Common?. Immunologic Research. 32(1-3). 267–292. 5 indexed citations

14.

Levisetti, Matteo. (2003). Autoantibodies and CD4 T cells target a cell retroviral envelope protein in non-obese diabetic mice. International Immunology. 15(12). 1473–1483. 13 indexed citations

15.

Schmidt, Robert E., Denise Dorsey, Lucie N. Beaudet, et al.. (2003). Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy. American Journal Of Pathology. 163(5). 2077–2091. 61 indexed citations

16.

Zhou, Yun-Ping, J C Pena, Michael W. Roe, et al.. (2000). Overexpression of Bcl-x_Lin β-cells prevents cell death but impairs mitochondrial signal for insulin secretion. American Journal of Physiology-Endocrinology and Metabolism. 278(2). E340–E351. 94 indexed citations

17.

Theriault, Betty, J. Richard Thistlethwaite, Matteo Levisetti, et al.. (1999). INDUCTION, MAINTENANCE, AND REVERSAL OF STREPTOZOTOCIN-INDUCED INSULIN-DEPENDENT DIABETES MELLITUS IN THE JUVENILE CYNOMOLGUS MONKEY (Macaca fascilularis)1. Transplantation. 68(3). 331–337. 52 indexed citations

18.

Pontoglio, Marco, Séamus Sreenan, S. Mark Roe, et al.. (1998). Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.. Journal of Clinical Investigation. 101(10). 2215–2222. 273 indexed citations

19.

Dukes, Iain, Séamus Sreenan, Michael W. Roe, et al.. (1998). Defective Pancreatic β-Cell Glycolytic Signaling in Hepatocyte Nuclear Factor-1α-deficient Mice. Journal of Biological Chemistry. 273(38). 24457–24464. 138 indexed citations

20.

Levisetti, Matteo, Philip Padrid, Gregory L. Szot, et al.. (1997). Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. The Journal of Immunology. 159(11). 5187–5191. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact